ArticleCancer chemotherapy and pharmacology2018

A population pharmacokinetic/toxicity model for the reduction of platelets during a 48-h continuous intravenous infusion of the histone deacetylase inhibitor belinostat.

Cody J Peer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.